421 related articles for article (PubMed ID: 28577947)
1. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
[TBL] [Abstract][Full Text] [Related]
2. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
[TBL] [Abstract][Full Text] [Related]
3. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
[TBL] [Abstract][Full Text] [Related]
5. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
8. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
9. Negative EBUS-TBNA Predicts Very Low Prevalence of Mediastinal Disease in Staging of Non-Small Cell Lung Cancer.
Taverner J; Cheang MY; Antippa P; See K; Irving LB; Steinfort DP
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):177-80. PubMed ID: 26905440
[TBL] [Abstract][Full Text] [Related]
10. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
[TBL] [Abstract][Full Text] [Related]
11. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
12. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
[TBL] [Abstract][Full Text] [Related]
13. Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.
Wang J; Welch K; Wang L; Kong FM
Clin Lung Cancer; 2012 Mar; 13(2):81-9. PubMed ID: 22056226
[TBL] [Abstract][Full Text] [Related]
14. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
[TBL] [Abstract][Full Text] [Related]
15. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
[TBL] [Abstract][Full Text] [Related]
16. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
17. Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients.
Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar' A; Atasalihi A; Kir A
Acta Chir Belg; 2012; 112(3):219-25. PubMed ID: 22808763
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
[TBL] [Abstract][Full Text] [Related]
19. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
20. Clinical Misstagings and Risk Factors of Occult Nodal Disease in Non-Small Cell Lung Cancer.
Dyas AR; King RW; Ghanim AF; Cerfolio RJ
Ann Thorac Surg; 2018 Nov; 106(5):1492-1498. PubMed ID: 29908981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]